Everything below concerns synthetic peptide. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-08-13. Numbers and descriptions here follow the published literature rather than marketing material.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
| Property | Value | Notes |
|---|---|---|
| Primary research area | Obesity and metabolic regulation | Studied in cell, animal, and human models |
| Highest reported trial phase | Phase II | Public summaries describe mixed results |
| Common route in trials | Subcutaneous injection | Typical for peptide therapeutics |
| Regulatory example | 2013 Australian anti-doping review | Classification was debated at the time |
| Approval status | Not approved as a human medicine | Status can change by jurisdiction |
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.
Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.
=== Category:EC 3.13 (act on carbon–sulfur bonds) === EC 3.13.1.1: UDP-sulfoquinovose synthase EC 3.13.1.3: 2'-hydroxybiphenyl-2-sulfinate desulfinase EC 3.13.1.4: 3-sulfinopropanoyl—CoA desulfinase EC 3.13.1.5: Carbon disulfide hydrolase EC 3.13.1.6: (CysO sulfur-carrier protein)-S-L-cysteine hydrolase EC 3.13.1.7: Carbonyl sulfide hydrolase EC 3.13.1.8: S-adenosyl-L-methionine hydrolase (adenosine-forming)
== P == Pangaea – paleontology – parallel evolution – paraphyletic – parasitism – parasitology – parthenogenesis – passive transport – Patau syndrome – paternity test – PCR – PCR mutagenesis – pentose phosphate pathway – peptide – peptide bond – peripheral protein – peroxisome – Pfeffer cell – phage – phagocytosis – phenotype – phloem – phospholipid – phospholipid bilayer – phosphorylation – photobiology – photolysis – photon – photophosphorylation – photorespiration – photosynthesis – photosynthesis – photosystem I – photosystem II – phycobilin – phycobiliprotein – phycocyanin – phycology – phylogenetics – phylogeny – phylogenetic tree – physiology – pigment – placenta – plankton – plant – plantae – plant physiology – plant sexuality – plasma membrane – plasmid – plasmolysis – plastid – plate tectonics – point mutation – pollenizer – pollination – pollinator – polymerase chain reaction – polypeptide – polyploidy – polysaccharide – population – population dynamics – population ecology – population genetics – potential energy – predation – pregnancy – primary nutritional groups – primary structure – primer – prion – prokaryote – prometaphase – promoter – prophage – prophase – proprioception – proteasome – protein biosynthesis – protein – protein translocation – proteolysis – proteome – proteomics – protist – protista – proton pump – protozoa – pseudopod – pteridophyte – Punnett square – purine – punctuated equilibrium – pyrimidine – pyruvate oxidation –
== Precursors == The earliest use of chromatography is sometimes attributed to German chemist Friedlieb Ferdinand Runge, who in 1855 described the use of paper to analyze dyes. Runge dropped spots of different inorganic chemicals onto circles of filter paper already impregnated with another chemical, and reactions between the different chemicals created unique color patterns. According to historical analysis of L. S. Ettre, however, Runge's work had "nothing to do with chromatography" (and instead should be considered a precursor of chemical spot tests such as the Schiff test). In the 1860s, Christian Friedrich Schönbein and his student Friedrich Goppelsroeder published the first attempts to study the different rates at which different substances move through filter paper. Schönbein, who thought capillary action (rather than adsorption) was responsible for the movement, called the technique capillary analysis, and Goppelsroeder spent much of his career using capillary analysis to test the movement rates of a wide variety of substances. Unlike modern paper chromatography, capillary analysis used reservoirs of the substance being analyzed, creating overlapping zones of the solution components rather than separate points or bands. Work on capillary analysis continued, but without much technical development, well into the 20th century. The first significant advances over Goppelsroeder's methods came with the work of Raphael E.
=== 2020 census === As of the 2020 census, Albany had a population of 56,472. The median age was 37.8 years, 36.5 for males and 39.0 for females. 22.3% of residents were under the age of 18 and 18.0% were 65 years of age or older. The gender makeup was 48.7% male and 51.3% female, which corresponds to 94.9 males for every 100 females overall and 92.2 males for every 100 females age 18 and over. 99.8% of residents lived in urban areas, while 0.2% lived in rural areas. There were 22,157 households in Albany, of which 30.0% had children under the age of 18 living in them. Of all households, 46.2% were married-couple households, 17.4% were households with a male householder and no spouse or partner present, and 27.1% were households with a female householder and no spouse or partner present. About 26.7% of all households were made up of individuals and 12.5% had someone living alone who was 65 years of age or older. There were 23,105 housing units, of which 4.1% were vacant. Among occupied housing units, 58.7% were owner-occupied and 41.3% were renter-occupied. The homeowner vacancy rate was 0.9% and the rental vacancy rate was 4.7%. The racial makeup of the city was 79.5% White, 0.8% African American, 1.4% American Indian or Alaska Native, 1.8% Asian, 0.3% Native Hawaiian or Pacific Islander, 5.3% from other races, and 10.9% from two or more races; Hispanic or Latino residents of any race were 14.1% of the population.
Sources: en.wikipedia.org
Attempts by customers to circumvent the BSA, generally by structuring cash deposits to amounts lower than US$10,000 by breaking them up and depositing them on different days or at different locations also violates the law. The financial database created by these reports is administered by the U.S.'s Financial Intelligence Unit, called the Financial Crimes Enforcement Network (FinCEN), located in Vienna, Virginia. The reports are made available to U.S. criminal investigators, as well as other FIU's around the globe, and FinCEN conducts computer-assisted analyses of these reports to determine trends and refer investigations. The BSA requires financial institutions to engage in customer due diligence, or KYC, which is sometimes known in parlance as know your customer. It includes obtaining satisfactory identification to assure that the account is in the customer's actual name and understanding the expected nature and source of the money that flows through the customer's accounts. Other customers, such as those with private banking accounts and those of foreign government officials, are subjected to enhanced due diligence because the law deems that those accounts are at a higher risk for money laundering. All accounts are subject to ongoing monitoring, in which internal bank software scrutinizes transactions and flags for manual inspection those that fall outside specific parameters. If a manual inspection reveals that the transaction is suspicious, the institution should file a Suspicious Activity Report.
== External links == Sophora flavescens Ait. Ya Ling, Jian; Ying Zhang, Guo; Jie Cui, Zhao; Kai Zhang, Chang (2007). "Supercritical fluid extraction of quinolizidine alkaloids from Sophora flavescens Ait. and purification by high-speed counter-current chromatography" (PDF). Journal of Chromatography A. 1145 (1–2): 123–127. doi:10.1016/j.chroma.2007.01.080. PMID 17289059. Krishna, Panthati Murali; Knv, Rao; S, Sandhya; Banji, David (2012). "A review on phytochemical, ethnomedical and pharmacological studies on genus Sophora, Fabaceae". Revista Brasileira de Farmacognosia. 22 (5): 1145–1154. doi:10.1590/S0102-695X2012005000043.
== Further reading == Elsie, Robert (2019). The Albanian Bektashi: history and culture of a Dervish order in the Balkans. London: I.B. Tauris. ISBN 978-1-78831-569-2. OCLC 1108619669. Yürekli, Zeynep (2012). Architecture and hagiography in the Ottoman Empire : the politics of Bektashi shrines in the classical age. Farnham, Surrey Burlington, VT: Ashgate. ISBN 978-1-4094-1106-2. OCLC 776031990. Frashëri, Naim Bey. Fletore e Bektashinjet. Bucharest: Shtypëshkronjët të Shqipëtarëvet, 1896; Reprint: Salonica: Mbrothësia, 1909. 32 pp.
1 On 3 March 2001, Minister for Planning and Infrastructure Alannah MacTiernan, whose portfolio included road safety, lost her licence after being booked for driving at 98 km/h in a 60 km/h zone near Pinjarra. On 9 March 2001, Premier Gallop appointed Minister for Police Michelle Roberts as Minister assisting the Minister for Planning and Infrastructure with respect to Road Safety, meaning that Roberts would chair the Ministerial Council on Road Safety and be responsible for three Acts of Parliament. 2 The parliamentary secretaries were not appointed at the same time as the rest of the Ministry. A separate announcement was made on 23 March 2001 confirming their appointments. 3 On 27 June 2003, a Cabinet reshuffle removed Health from Bob Kucera and Housing and Works from Tom Stephens, reallocating the portfolios to Jim McGinty and Nick Griffiths respectively. The membership of the Cabinet remained unchanged. 4 On 16 September 2004, Tom Stephens MLC resigned from the Ministry and from Parliament in order to contest the seat of Kalgoorlie at the October 2004 federal election. Kim Chance adopted the portfolios before they were reassigned to Ljiljanna Ravlich, who was promoted from parliamentary secretary to Minister on 21 September 2004.
== Reactions == Thionyl chloride is mainly used in the industrial production of organochlorine compounds, which are often intermediates in pharmaceuticals and agrochemicals. It usually is preferred over other reagents, such as phosphorus pentachloride, as its by-products (HCl and SO2) are gaseous, which simplifies purification of the product. Many of the products of thionyl chloride are themselves highly reactive and as such it is involved in a wide range of reactions.
Sources: en.wikipedia.org
No major medicines regulator appears to have approved AOD-9604 for human therapeutic use. It has been studied in clinical trials, but those programs did not result in a marketed drug.
It became prominent during a 2013 Australian sports investigation that examined whether it was a prohibited growth-hormone-related substance. Subsequent interpretations and list updates have varied, so current rules should be checked directly.
Published summaries generally report limited or inconsistent weight-loss effects, and complete trial data are not widely available. The studies were not sufficient to establish it as an effective obesity treatment.
No, it is a synthetic peptide fragment corresponding to a small portion of hGH. It is not the full 191-amino-acid hormone and does not reproduce all of hGH's effects.